A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer.

Published in:

2012

By:

• Spira AI;
• Iannotti NO;
• Savin MA;
• Neubauer M;
• Gabrail NY;
• Yanagihara RH;
• Zang EA;
• Cole PE;
• Shuster D;
• Das A;
• Spira, Alexander I;
• Iannotti, Nicholas O;
• Savin, Michael A;
• Neubauer, Marcus;
• Gabrail, Nashat Y;
• Yanagihara, Ronald H;
• Zang, Edith A;
• Cole, Patricia E;
• Shuster, Dale;
• Das, Asha

Publication type:

journal article